OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-12-31-accounts

Registered number: 11843293 Charity number: 1185863

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee) TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

CONTENTS

Page
Reference and administrative details of the charity, its trustees and advisers 1
Trustees' Report 2 - 5
Trustees' Responsibilities Statement 6
Independent Auditor's Report on the Financial Statements 7 - 10
Statement of Financial Activities 11
Balance Sheet 12
Notes to the Financial Statements 13 - 21

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2021

Trustees M Szubski
A Martyn Roe (appointed 29 October 2021)
P B Worrall (resigned 31 July 2021)
Company registered
number
11843293
Charity registered
number
1185863
Registered office
Suite 1, 3rd Floor 11 - 12 St. James's Square
London
SW1Y 4LB
Company secretary
Vistra Cosec Limited
Independent auditor
Blick Rothenberg Audit LLP
Chartered Accountants
Statutory Auditor
16 Great Queen Street
Covent Garden
London
WC2B 5AH
Bankers
JPMorgan Chase Bank
25 Bank Street
Canary Wharf
London
E14 5JP
Solicitors
Ropes & Gray International LLP
60 Ludgate Hill
London
EC4M 7AW

Page 1

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

The trustees present their annual report together with the audited financial statements of the Fund For Cures UK, Ltd. for the year 1 January 2021 to 31 December 2021. The Annual Report serves the purposes of both a trustees' report and a directors' report under company law. The trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Objectives and activities

The mission of Fund For Cures UK, Ltd. is to advance promising new scientific and medical discoveries into treatments and cures. Fund For Cures UK, Ltd. is newly founded and modeled after a national charitable medicine initiative in the United States with a successful track record. We seek to accelerate the best science from labs at world leading universities and hospitals, collaborating with academic and industry physicians and scientists, through patient care in clinical trials and developing new medicines to treat patients for unmet needs.

Physicians, scientists and principal investigators at accredited UK institutions are eligible to apply for grant funding to support charitable research or drug development activities. Fund for Cures UK, Ltd. makes no claim by virtue of any grant to ownership of work product invented or developed with such grant funding and the recipient retains full authority for making all decisions in connection with the project, including pursuing, maintaining and enforcing patent, copyright and other intellectual property and development rights.

The organisation is part of an international initiative to help translate scientific discoveries into medicines for the benefit of society as a whole. We aim to respond to the public's emerging health needs, and to address a range of disease areas and therapeutic needs, with an emphasis on unmet needs. Through the funding and translational drug development expertise we provide, we will help bridge the critical gap that currently exists within drug development between basic discovery of potentially new or improved medicines and clinical patient care. The organisation's support of the advancement of promising discoveries into medicines for unmet needs will provide a benefit to the public in general and to the public class of people that suffer rare or under-regarded or other diseases for which orphan drugs or other medicinal products have not yet been developed.

a. Policies and objectives

The objects (‘Objects’) for which Fund For Cures UK, Ltd. is established are to protect, advance and promote the health of the public for the public benefit within the UK and elsewhere in the world by:

(a) establishing centres of excellence to promote health and well-being, and to prevent, diagnose and treat illness and disease;

(b) affiliating with universities, medical centres, and research organisations, scientific organisations and other like organisations within the UK and elsewhere in the world to work together to develop and support high quality health, medical and scientific research into the nature, causes, diagnosis, prevention, treatment and cure of disease; and

(c) awarding grants and providing other support to enable scientists and medical researchers to advance their research into the nature, causes, diagnosis, prevention, treatment and cure of disease.

In setting objectives and planning for activities, the trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

Page 2

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021

(continued)

b. Strategies for achieving objectives

Fund For Cures UK, Ltd. has established a rare disease centre and affiliation agreement with a leading UK medical research university. The charity serves as a focus for bilateral rare disease research projects within the rare disease centre and national hub for a UK-wide charitable grants program that provides support to scientists and medical researchers at UK universities to advance their research into the nature, causes, diagnosis, prevention, treatment and cure of disease. The charity seeks to develop new therapeutics and medicines for unmet needs and supports a UK Director, Scientific Advisory Council and research support personnel to help advance these objectives. The charity also promotes the Harrington UK Rare Disease award, giving support to individual researchers around the UK.

c. Review of activities

Fund For Cures UK, Ltd made significant progress planning for and implementing the rare disease centre. The centre will combine the parties’ respective research and drug discovery capabilities with the goal of delivering new medicines to patient suffering from rare diseases. The Centre research initiative will focus on 3 areas: rare cancers, paediatric developmental diseases and neurological diseases. Despite disruptions caused by the coronavirus pandemic, Fund For Cures UK, Ltd. made a UK - nationwide call for proposals under the rare disease programme. Fund For Cures UK, Ltd. is actively planning and exploring ways to extend other drug development programs into UK universities consistent with programme cycles.

In the prior year, Fund for Cures UK, Ltd. entered into an agreement with Oxford University and its parent, University Hospitals Research & Education Collaborations LLC, to jointly develop the Centre and fund its operation for an initial period of five years.

In the period under review, Fund for Cures UK, Ltd. has started to make funding payments to other UK based researchers who were recipients of the 2021 Harrington UK Rare Disease award. These are annual payments to be made for each of two consecutive years.

Achievements and performance

a. Main achievements of the charity

The inaugural Harrington UK Rare Disease program received 47 applications from 17 different UK institutions. Following rigorous academic and industry review, the Scientific Advisory Council selected the following 5 award winners for rare disease grant awards:

The winners of the 2020 Harrington UK Rare Disease award were selected late in the year, meaning payments would not begin until 2021 once contracts have been signed.

The winning institutions will receive £100,000, drug development expertise and project management support for the 2 year award, and the opportunity for additional funding based on progress.

Page 3

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021

Achievements and performance (continued)

b. Duty to promote the success of the charity to achieve its charitable purposes

Fund For Cures UK, Ltd. and its Trustees are committed to act in good faith to promote the charitable Objects and have complied with their duty to have due regard to the guidance on public benefit published by the Commission in exercising their powers or duties.

Financial review

a. Going concern

After making appropriate enquiries, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. The Fund for Cures UK, Ltd. Treasurer has reviewed the budget and forecasts for the 12-month period following this report. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.

b. Reserves policy

Fund For Cures UK, Ltd. is developing a comprehensive reserves policy and capitalization strategy to support its mission. Fund For Cures UK, Ltd. policy is not to commit expenditures beyond approved budget and available restricted or unrestricted funds in its UK bank account or available from its parent organization.

c. Financial review of the year

During the year, the charity received funding of £347,079 from its parent and used those funds to develop the institute by making grants to Oxford University and the University of Cardiff, net assets at the period end were £46,110 representing prepaid grants less accrued costs.

Structure, governance and management

a. Constitution

Fund for Cures UK, Ltd. is registered as a charitable company limited by guarantee and was set up by Articles of Association.

b. Methods of appointment or election of trustees

The management of the charity is the responsibility of the trustees who are elected and co-opted under the terms of the Articles of Association.

c. Financial risk management

The trustees have assessed the major risks to which the charity is exposed, in particular those related to the operations and finances of the charity, and are satisfied that systems and procedures are in place to mitigate exposure to the major risks.

Page 4

FUNO FOR CURES Uli LTD. IA Company Limited by Gvarnntee} TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2021 Struclure. govèrnance and mJnag•m•nt Icontinuldl d. Engagement with 8￿pp•s￿$. ¢￿tomer￿ and othern Fund For CuTes UK, Ltd. and ils Trusteès are commrtted to acl in good faith to foster the companys business felatlOa5hips wrth suppliers, customers and other5. Fund For Cure5 UK. Ltd. confirms it has acted in due regard to suc inlere5ts in sUpportW￿ new madiune de1 of ￿5t st)e￿ based ￿ meril. Plans for fuiuve pgritids Fund For Cures VK. Ltd. is recenlty founded and activety e¥abJating opporlurMt¥es where it can make the most impacl based on unmet needs. We will continue lo advance our charitable Objects as described at￿ and prudently expand collaboration5 with leading institution5 deveh)pment tsnd5 to further ihal purpose. Dlsclosure of infommtiofft to audstor Each oflhe petsons who are trustees at Ihe time Ihis Trustees. Report is approved ha5 confimied that.. $0 far as Ihat Iruslee is aware. there 15 no rdevant audit inforrnati￿ of which tharilrfs auditor unaware. and that trustee has taken all the steps thai ought to have been taken as a trustee in order to be aware ol any rèlevant audit informab.on and to estawish that the audittir is aware of th infomation. Auditor The avdrtor, 8h.ck Rolhenberg Audrt LLP. has indicated his wlliThJress to continue in officè. The desmjnaled Iwsteès will propose a rnot￿n reappirting the at a neling tsf Ihe truslees. Approved by oriler of the members of Ihe board oflwslees s*Jned on th•1¥ behalf ty. Szub$ki Trustee. Fund for Cures UK. Ltd. Date." 26 September 2022 Page 5

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31 DECEMBER 2021

The trustees (who are also the directors of the charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year. Under company law, the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Page 6

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF FUND FOR CURES UK, LTD.

FOR THE YEAR ENDED 31 DECEMBER 2021

Opinion

We have audited the financial statements of Fund for Cures UK, Ltd. (the 'charity') for the year ended 31 December 2021 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Page 7

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF FUND FOR CURES UK, LTD. (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report.

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Page 8

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF FUND FOR CURES UK, LTD. (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We assessed the susceptibility of the charity's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-comliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Page 9

FUND FOR CURES UK, LTD.

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF FUND FOR CURES UK, LTD. (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2021

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.

Mark Hart (senior statutory auditor)

for and on behalf of Blick Rothenberg Audit LLP

Chartered Accountants Statutory Auditor

16 Great Queen Street Covent Garden London WC2B 5AH

Date: 27 September 2022

Page 10

FUND FOR CURES UK, LTD.

(A Company Limited by Guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2021

Note
Income from:
Donations and legacies
3
Total income
Expenditure on:
Charitable activities
4
Total expenditure
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
Year ended
31 December
2021
£
347,079
347,079
362,226
362,226
(15,147)
63,300
(15,147)
48,153		 Total
funds
Year ended
31 December
2021
£
347,079
347,079
362,226
362,226
(15,147)
63,300
(15,147)
48,153		 Total
funds
Period ended
31 December
2020
£
369,194
369,194
305,894
305,894
63,300
-
63,300
63,300

The statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 13 to 21 form part of these financial statements.

Page 11

REGISTERED NUMBER.. 11843293 FUND FOR CURES UK LTD. IA Company Limited by Guarantee} BALANCE SHEEr FOR THE YEAR ENDED 31 DECEMBER 2021 29 February 2020 2021 Debtors Cash at bank and in hand 72,500 72.500 n.500 CTeditOTS'. amounts faI￿ng due within or year 10 1243471 {9.2001 Not ¢urrentassets 48.153 63,300 Total net assets 48.153 63,300 Charfty funds Restricted funds Unrestricted funds 12 12 48,153 63,300 Total lunds 48.1S3 63,300 The trustees acknowledge thèir responsibilrtie5 for ojmptying the requirem•niS of the Act wffh respe(1 to accounting records and prepafalion of finan¢ia ststement& The finanraal statements approved and aulhorised for is5Ug by the trustees and signed on lh￿r behaff by. M Szubski Trustee, Fund for cU￿S UK, Ltd. Dale." 26 September 2022 The notes on pages 13 to 21 form part of these financial statements. Page 12

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

1. General information

The charity is a company limited by guarantee and is incorporated and registered in England and Wales. Its registered office and principal place of business is Suite 1, 3rd Floor 11 - 12 St. James's Square, London, SW1Y 4LB.

The financial statements are presented in Sterling (£), which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Fund for Cures UK, Ltd. meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Going concern

The charity continues to trade with the support of its parent. After making enquiries, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least twelve months from the date these financial statements were approved. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Income

All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably. Donations are recognised when the charity has received confirmation from the donor of the amount receivable and there is certainty of receipt.

2.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the charity's objectives, as well as any associated support costs.

Page 13

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

2. Accounting policies (continued)

2.4 Expenditure (continued)

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

2.5 Financial instruments

The charity has elected to apply Sections 11 and 12 of FRS 102 in respect of financial instruments.

Financial assets and financial liabilities are recognised when the charity becomes party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities.

The charity’s policies for its major classes of financial assets and financial liabilities are set out below.

Financial assets

Basic financial assets, including trade and other debtors, cash and bank balances, intercompany working capital balances, and intercompany financing are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Financial liabilities

Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Impairment of financial assets

Financial assets measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit and loss account.

Page 14

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

2. Accounting policies (continued)

Financial instruments (continued)

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset's carrying amount and the best estimate of the amount the company would receive for the asset if it were to be sold at the reporting date.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between the asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If the financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets and financial liabilities

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Offsetting of financial assets and financial liabilities

Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

2.6 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.7 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.

Page 15

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

3. Income from donations and legacies

Unrestricted Unrestricted Total
funds funds
Year ended Year ended
31 31
December December
2021 2021
£ £
Donations 347,079 347,079
Total 2021 347,079 347,079
Unrestricted Total
funds funds
Period ended Period ended
31 31
December December
2020 2020
£ £
Donations 369,194 369,194

4. Analysis of expenditure on charitable activities

Summary by fund type

Unrestricted
funds
Year ended
31
December
2021
£
Grants payable, to Oxford University
290,000
Grants payable, to the University of Cardiff
50,000
Bank charges
4,874
Interest payable
5
Accountancy fees
17,347
Total 2021
362,226		 Total
funds
Year ended
31
December
2021
£
290,000
50,000
4,874
5
17,347
362,226

Page 16

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

4. Analysis of expenditure on charitable activities (continued)

Summary by fund type (continued)

Unrestricted
Total
funds
funds
Period ended
Period ended
31
31
December
December
2020
2020
£
£
Charitable Activities 290,000
290,000
Bank charges 4,428
4,428
Interest payable 76
76
Accountancy fees 11,390
11,390
305,894
305,894

5. Analysis of expenditure by activities

Grants payable, to Oxford University
Grants payable, to the University of Cardiff
Bank charges
Interest payable
Accountancy fees
Total 2021		 Grant
funding of
activities
Year ended
31
December
2021
£
290,000
50,000
-
-
-
340,000		 Support
costs
Year ended
31
December
2021
£
-
-
4,874
5
17,347
22,226		 Total
funds
Year ended
31
December
2021
£
290,000
50,000
4,874
5
17,347
362,226

Page 17

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

5. Analysis of expenditure by activities (continued)

Grant
funding of Support Total
activities costs funds
Period ended Period ended Period ended
31 31 31
December December December
2020 2020 2020
£ £ £
Charitable Activities 290,000 - 290,000
Bank charges - 4,428 4,428
Interest payable - 76 76
Accountancy fees - 11,390 11,390
290,000 15,894 305,894

6. Analysis of grants

Grants to
Total
Institutions
funds
Year ended
Year ended
31
31
December
December
2021
2021
£
£
Grants, to Oxford University 290,000
290,000
Grants, to the University of Cardiff 50,000
50,000
340,000
340,000
Grants to
Total
Institutions
funds
Period ended
Period ended
31
31
December
December
2020
2020
£
£
Grants, to Oxford University 290,000
290,000

Page 18

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

7. Auditor's remuneration

The auditors' remuneration was £12,000 including VAT ( 2020 - £11,390 ) , and other accounting services of £5,200.

8. Trustees' remuneration and expenses

During the year, no trustees received any remuneration or other benefits (2020 - £NIL).

During the year ended 31 December 2021, no trustee expenses have been incurred (2020 - £NIL).

9. Debtors

2021 2020
£ £
Due within one year
Prepayments and accrued income 72,500 72,500

10. Creditors: Amounts falling due within one year

Trade creditors
Accruals and deferred income		 2021
£
-
25,347
25,347		 2020
£
1,200
8,000
9,200

11. Grant commitments

At 31 December 2021 the charity had commitments to make future grant payments under noncancellable contracts:

University College London
University of Newcastle
Oxford University
University of Cardiff		 2021
£
200,000
100,000
100,000
50,000
450,000		 2020
£
-
-
-
-
-

Page 19

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

12. Statement of funds

Statement of funds - current year

Unrestricted funds
General funds - all funds
Statement of funds - prior year
Unrestricted funds
General Funds - all funds		 Balance at 1
January
2021
£
63,300		 Income
£
347,079
Income
£
369,194		 Expenditure
£
(362,226)
Expenditure
£
(305,894)		 Balance at
31
December
2021
£
48,153
Balance at
31
December
2020
£
63,300

13. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2021
£
Current assets
73,500
Creditors due within one year
(25,347)
Total
48,153		 Total
funds
2021
£
73,500
(25,347)
48,153

Page 20

FUND FOR CURES UK, LTD. (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

13. Analysis of net assets between funds (continued)

Analysis of net assets between funds - prior year

Current assets
Creditors due within one year
Total		 Unrestricted
funds
2020
£
72,500
(9,200)
63,300		 Total
funds
2020
£
72,500
(9,200)
63,300

14. Parent and ultimate controlling party

The charity's immediate parent is University Hospitals Research & Education Collaborations LLC, a company incorporated in the United States of America.

There is no ultimate controlling party.

Page 21